Standard Biotools SEC filings: 8-K
Filter: All · 8-K · 10-Q · 10-K · Form 4
Departure/appointment of directors or officers · Submission of matters to a vote of security holders · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedStandard BioTools stockholders approve Treeline merger share issuance, 1-for-20 to 1-for-40 reverse split and Mass Cytometry sale
Other events
AI summary, unreviewedStandard BioTools 8-K supplements Treeline merger proxy after 15 demand letters and two New York complaints; Centerview values company at $1.14 per share vs. $0.62 pre-filing market cap
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedStandard BioTools Completes Sale of Microfluidics Business to ARCHIMED, Which Will Operate as Biomark Scientific
Regulation FD disclosure · Financial statements and exhibits
Entry into a material definitive agreement · Termination of a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
Delisting notice / failure to meet listing standard